AZ vaccination victim dies again in Denmark…”Resumption of use seems to be delayed”

Input 2021.03.21 11:19

“Within less than 14 days of vaccination, 1 person died and 1 person had a brain hemorrhage”
Specific information, such as the timing of the onset of related symptoms, is not disclosed.
The vaccination was stopped for 2 weeks due to the death of a 60-year-old woman on the 11th

In Denmark, a global pharmaceutical company AstraZeneca (AZ) and a medical worker vaccinated with the Corona 19 vaccine at Oxford University in the UK died, and another was in critical condition due to cerebral hemorrhage, Reuters reported on the 20th (local time).

According to reports, Danish health authorities received two serious reports about the AZ vaccine that day. “This happened within 14 days of both AZ vaccines.” However, it did not disclose specific information, such as when related symptoms began to appear to them.

Denmark temporarily suspended the vaccination for two weeks due to the death of a 60-year-old woman who received the AZ vaccine in her home country after a blood clot on the 11th. Reuters said it would take more time before deciding to resume use, as the death case occurred again. The authorities said, “We will thoroughly investigate the association of the vaccine with cases suspected of serious side effects.”

Earlier, the European Medicines Agency (EMA), an agency for evaluating medicines and vaccines in the European Union, announced on the 18th that “AZ vaccine is safe and has a greater benefit than the risk of side effects” in connection with a report that blood clots were formed after vaccination with AZ. . Accordingly, some countries, such as Germany, France, and Italy, where AZ vaccination was discontinued, have resumed vaccination according to the recommendations of the EMA.

AstraZeneca’s side avoided an immediate answer in connection with this case. However, “the safety of the vaccine is a top priority, and we welcome European regulators to confirm the effectiveness of our vaccine,” and reaffirmed the existing position, “We hope that vaccination can be resumed across Europe after a careful decision by regulatory authorities.” did.